Eculizumab for pediatric anti-FH antibody-associated atypical hemolytic uremic syndrome: promising results but critical gaps remain

Pediatr Nephrol. 2024 Nov 6. doi: 10.1007/s00467-024-06576-2. Online ahead of print.
No abstract available

Publication types

  • Letter